Here we report the first cloned N-ethyl-nitrosourea (ENU)-derived mouse model of diabetes. GENA348 was identified through free-fed plasma glucose measurement, being more than 2 SDs above the population mean of a cohort of >1,201 male ENU mutant mice. The underlying gene was mapped to the maturity-onset diabetes of the young (MODY2) homology region of mouse chromosome 11 (logarithm of odds 6.0). Positional candidate gene analyses revealed an A to T transversion mutation in exon 9 of the glucokinase gene, resulting in an isoleucine to phenylalanine change at amino acid 366 (I366F). Heterozygous mutants have 67% of the enzyme activity of wild-type littermates (P < 0.0012). Homozygous mutants have less enzyme activity (14% of wildtype activity) and are even less glucose tolerant. The GENA348 allele is novel because no mouse or human diabetes studies have described a mutation in the corresponding amino acid position. It is also the first glucokinase missense mutation reported in mice and is homozygous viable, unlike the global knockout mutations. This work demonstrates that ENU mutagenesis screens can be used to generate models of complex phenotypes, such as type 2 diabetes, that are directly relevant to human disease. Diabetes 53: [1577][1578][1579][1580][1581][1582][1583] 2004 T ype 2 diabetes is a heterogeneous metabolic disorder characterized by hyperglycemia resulting from defects in insulin action and/or insulin secretion. The underlying causes are both genetic and environmental (notably for the latter, obesity [1]).Several bodies of evidence indicate a genetic component for the disease (lifetime risk of first-degree relatives [2], twin studies [3,4], and genetic admixture studies [5]), and there has been some success in mapping genes to chromosomal regions in human populations (6). Earlyonset monogenic forms of diabetes account for ϳ2-5% of all diabetic patients. This phenomenon is known as maturity-onset diabetes of the young (MODY) and is caused by mutations in a variety of genes, including glucokinase (Gck), and the transcription factors hepatocyte nuclear factor 1␣ (HNF-1␣), HNF-4␣, HNF-1, insulin promoter factor-1, and neuroD1 (6). To date, one gene mapped in multigenic type 2 diabetes in Mexican Americans and a Finnish ethnic subpopulation (Botnians) has been cloned, namely the Calpain 10 gene (7). The effect of this gene in European populations is uncertain (see, e.g., 8 -12). Polymorphisms in other genes have been identified by association with type 2 diabetes, including, for example, peroxisome proliferator-activated receptor ␥ and the KCNJ11 component of the ATP-sensitive potassium channel in -cells (reviewed in 13).The identification of mouse diabetes genes serves as an adjunct to human studies by exploiting the high statistical power facilitated by large controlled crosses of genetically uniform strains to identify relevant genes even when such gene effects are small (14). A potential source of mice encompassing allelic series across all possible gene determinants of glucose homeostasis is ge...